首页> 美国卫生研究院文献>Clinical Psychopharmacology and Neuroscience >Efficacy of Adenine in the Treatment of Leukopenia and Neutropenia Associated with an Overdose of Antipsychotics or Discontinuation of Lithium Carbonate Administration: Three Case Studies
【2h】

Efficacy of Adenine in the Treatment of Leukopenia and Neutropenia Associated with an Overdose of Antipsychotics or Discontinuation of Lithium Carbonate Administration: Three Case Studies

机译:腺嘌呤治疗白细胞减少和中性粒细胞减少症与过量的抗精神病药或中止碳酸锂给药的疗效:三例研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Because adenine is effective for managing cases of radiation-induced and drug-induced leukopenia, it may be effective in cases of antipsychotic-induced leukopenia and neutropenia. Here, we report our experience with patients with leukopenia and neutropenia caused by an antipsychotic overdose or discontinuation of lithium carbonate, in whom adenine administration ameliorated the white blood cell and neutrophil counts. The progress of patients suggests that adenine is effective in cases of leukopenia and neutropenia associated with lithium carbonate discontinuation and an antipsychotic overdose.
机译:由于腺嘌呤对治疗辐射诱发和药物诱发的白细胞减少症有效,因此在抗精神病药物诱发的白细胞减少症和中性粒细胞减少症的病例中可能有效。在这里,我们报告了由抗精神病药物过量或碳酸锂停药引起的白细胞减少和中性粒细胞减少症患者的经验,其中腺嘌呤给药可改善白细胞和中性粒细胞计数。患者的进展表明,腺嘌呤对与碳酸锂停药和抗精神病药过量有关的白细胞减少和中性粒细胞减少症有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号